Smith Darren Charlton
SEC insider (Form 3/4/5 filer). CIK 0002122447. Group Chief Financial Officer at Telix Pharmaceuticals Ltd (TLX). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 7, 2026. Located in NORTH MELBOURNE.
Companies Smith Darren Charlton has filed insider reports for
- Telix Pharmaceuticals Ltd (TLX): Officer, Group Chief Financial Officer
Smith Darren Charlton
CIK: 0002122447
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (50.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TLX
Telix Pharmaceuticals Ltd
Officer